TY - JOUR
T1 - Effectiveness of a novel semi-closed barrier device with a personalized exhaust in cough aerosol simulation according to particle counts and visualization of particles
AU - Matsui, Ryohei
AU - Sasano, Hiroshi
AU - Azami, Takafumi
AU - Yano, Hisako
AU - Yoshikawa, Hiromi
AU - Yamagishi, Yota
AU - Goshima, Takahiro
AU - Miyazaki, Yuka
AU - Imai, Kazunori
AU - Tsubouchi, Marechika
AU - Matsuo, Yoichi
AU - Takiguchi, Shuji
AU - Hattori, Tomonori
N1 - Publisher Copyright:
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2022/2
Y1 - 2022/2
N2 - Oxygen therapy is an essential treatment for patients with coronavirus disease 2019, although there is a risk of aerosolization of additional viral droplets occurring during this treatment that poses a danger to healthcare professionals. High-flow oxygen through nasal cannula (HFNC) is a vital treatment bridging low-flow oxygen therapy with tracheal intubation. Although many barrier devices (including devices without negative pressure in the barrier) have been reported in the literature, few barrier devices are suitable for HFNC and aerosol infection control procedures during HFNC have not yet been established. Hence, we built a single cough simulator model to examine the effectiveness of three protective measures (a semi-closed barrier device, a personalized exhaust, and surgical masks) administered in isolation as well as in combination using particle counter measurements and laser sheet visualization. We found that the addition of a personalized exhaust to a semi-closed barrier device reduced aerosol leakage during HFNC without negative pressure. This novel combination may thus reduce aerosol exposure during oxygen therapy, enhance the protection of healthcare workers, and likely reduce nosocomial infection risk.
AB - Oxygen therapy is an essential treatment for patients with coronavirus disease 2019, although there is a risk of aerosolization of additional viral droplets occurring during this treatment that poses a danger to healthcare professionals. High-flow oxygen through nasal cannula (HFNC) is a vital treatment bridging low-flow oxygen therapy with tracheal intubation. Although many barrier devices (including devices without negative pressure in the barrier) have been reported in the literature, few barrier devices are suitable for HFNC and aerosol infection control procedures during HFNC have not yet been established. Hence, we built a single cough simulator model to examine the effectiveness of three protective measures (a semi-closed barrier device, a personalized exhaust, and surgical masks) administered in isolation as well as in combination using particle counter measurements and laser sheet visualization. We found that the addition of a personalized exhaust to a semi-closed barrier device reduced aerosol leakage during HFNC without negative pressure. This novel combination may thus reduce aerosol exposure during oxygen therapy, enhance the protection of healthcare workers, and likely reduce nosocomial infection risk.
KW - COVID-19
KW - high-flow nasal cannula
KW - nosocomial infection risk
KW - oxygen therapy
KW - personalized exhaust
KW - semi-closed barrier device
UR - http://www.scopus.com/inward/record.url?scp=85125392138&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125392138&partnerID=8YFLogxK
U2 - 10.1111/ina.12988
DO - 10.1111/ina.12988
M3 - Article
C2 - 35225390
AN - SCOPUS:85125392138
SN - 0905-6947
VL - 32
JO - Indoor Air
JF - Indoor Air
IS - 2
M1 - e12988
ER -